Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 8
- Prescribers & Clinics
Nine of the Ten Top CBPM Prescribers Are Pharmacists, FOI Data Shows
New data acquired by Business of Cannabis has, for the first time, shed light on the professional types behind England’s CBPM prescribing record, raising further questions about assertions that ‘10 doctors prescribe half of the UK’s medical cannabis’.
- International Regulation
How Countries Legalise Cannabis Matters More Than Whether They Do, Lancet Review Finds
Thirteen years ago, Uruguay became the first country on the planet to officially legalise cannabis for recreational (adult-use) purposes.
- US & Canada
DEA Selects Only Cannabis Opponents For Crucial June 29 Rescheduling Hearing
In the weeks since cannabis under a state medical licence was moved to Schedule III, US multi-state operators (MSOs) have wasted no time in capitalising on the historic reclassification.
- Public Markets
Listed – Part II: The Three Amigos
Trulieve’s uplisting to the NYSE, the first of its kind in US history, has undoubtedly caught the attention of every large North American cannabis operator.
- Medical Cannabis
France Sets July Deadline for Medical Cannabis Regulations as Withheld Study Shows Opioid Reductions
France’s health minister has confirmed to Agence France-Presse (AFP) that the delayed regulatory texts needed to push through its incoming generalised medical cannabis market will be published next month (July 2026).
- M&A Activity
Sanity Group Deepens Swiss Footprint With Astrasana Distribution Deal
Sanity Group has announced a new distribution partnership with Swiss cannabis operator Astrasana Holding AG, further expanding its footprint in the closely watched Swiss market.
- Pharmaceutical
Ananda Pharma Confirms Safety of MRX1 CBD Drug, as Clinical Pain Trials Approach
Ananda Pharma has taken another major step forward in bringing its flagship MRX1 CBD oral solution to market.
- Investment & Finance
Listed: Cannabis Finally Cracks America’s Major Exchanges
Cannabis stocks have, for the last five years or so, represented one of, if not the worst-performing, niche categories on any exchange.
- Data & Analysis
European Cannabis Insights Summit 2026: Patients & Politics Post-Reclassification
Since April 2024, Berlin has cemented its place as the spiritual centre of the European cannabis industry.
- Medical Cannabis
Do 10 Doctors Really Prescribe Half of England’s Medical Cannabis?
The UK’s medical cannabis market has long been a locked box when it comes to reliable data.
- Interviews
From Land to Brand: Why Cannabis’s Next Generation Is Going Asset-Light
Last year (fiscal year 2024/2025), Canada’s legal cannabis industry recorded revenues of CA$5.5bn, according to the latest figures from Statistics Canada.
- US & Canada
Mounting Legal Challenges Threaten Hearing to Extend Cannabis Rescheduling to Adult Use
The critical June 29 administrative hearing, set to determine whether the US will extend rescheduling efforts to recreational cannabis, is now set to be a fiercely contested event.
